Uncertainty clouds biosimilar market debut

By Chris Hanson-Ehlinger
Tue, Mar, 24, 2015 @ 11:03 AM

Phil DeNucci, RPh, managing consultant at The Burchfield Group, weighs in on biosimilars and how health plans can prepare for them in Drug Benefit News.

Latest

Uncertainty clouds biosimilar market debut

Chris Hanson-Ehlinger
Tue, Mar, 24, 2015 @ 11:03 AM

FDA approves Zarxio as the first U.S. biosimilar

Chris Hanson-Ehlinger
Wed, Mar, 11, 2015 @ 16:03 PM

Biosimilars drive competition, alleviate medication costs for plans

Chris Hanson-Ehlinger
Mon, Feb, 02, 2015 @ 14:02 PM

Complexity and cost of personalized medicine challenge health plan budgets

Chris Hanson-Ehlinger
Thu, Dec, 19, 2013 @ 14:12 PM
Privacy Policy